Taltirelin is a superagonist at the human thyrotropin-releasing hormone receptor

Frontiers in Endocrinology

Volumn 3, Issue OCT, 2012, Pages

  Thirunarayanan, Nanthakumar ^a   Raaka, Bruce M ^a   Gershengorn, Marvin C ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Humantrh receptor; Taltirelin; Thyrotropin releasing hormone

Indexed keywords

EID: 84874352289     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2012.00120     Document Type: Article

References (17)

1. Asai, H., Asahi, T., Yamamura, M., Yamauchi-Kohno, R., and Saito, A. (2005). Lack of behavioral tolerance by repeated treatment with taltirelin hydrate, a thyrotropin-releasing hormone analog, in rats. Pharmacol. Biochem. Behav. 82, 646-651.
2. Asai, H., Kinoshita, K., Yamamura, M., and Matsuoka, Y. (1999). Diversity of thyrotropin-releasing hormone receptors in the pituitary and discrete brain regions of rats. Jpn. J. Pharmacol. 79, 313-317.
3. Brown, W. (1999). Taltirelin. Tanabe Seiyaku. IDrugs 2, 1059-1068.
4. Duthie, S. M., Taylor, P. L., and Eidne, K. A. (1993). Characterization of the mouse thyrotrophin-releasing hormone receptor gene: an exon corresponds to a deletion in the rat cDNA. J. Mol. Endocrinol. 11, 141-149.
5. Engel, S., Neumann, S., Kaur, N., Monga, V., Jain, R., Northup, J., et al. (2006). Low affinity analogs ofthyrotropin-releasinghormoneare super-agonists. J. Biol. Chem. 281, 13103-13109.
6. Gary, K. A., Sevarino, K. A., Yarbrough, G. G., Prange, A. J. Jr., and Winokur, A. (2003). The thyrotropin-releasing hormone (TRH) hypothesis of homeostatic regulation: implications for TRH-based therapeutics. J. Pharmacol. Exp. Ther. 305,410-416.
7. Gershengorn, M. C. (1986). Mechanism of thyrotropin releasing hormone stimulation of pituitary hormone secretion. Annu. Rev. Physiol. 48, 515-526.
8. Horita, A. (1998). An update on the CNS actions of TRH and its analogs. Life Sci. 62, 1443-1448.
9. Horita, A., Carino, M. A., and Lai, H. (1986). Pharmacology of thyrotropin-releasing hormone. Annu. Rev. Pharmacol. Toxicol. 26, 311-332.
10. Khomane, K. S., Meena, C. L., Jain, R., and Bansal, A. K. (2011). Novel thyrotropin-releasing hormone analogs: a patent review. Expert Opin. Ther. Pat. 21, 1673-1691.
11. Kinoshita, K., Yamamura, M., and Sugihara, J. (1997). Distribution of thyrotropin-releasing hormone (TRH) receptors in the brain of the ataxic mutant mouse, rolling mouse Nagoya. Biol. Pharm. Bull. 20, 86-87.
12. Matre, V., Karlsen, H. E., Wright, M. S., Lundell, I., Fjeldheim, Å. K., Gabrielsen, O. S., et al. (1993). Molecular cloning of a functional human thyrotropin-releasing hormone receptor. Biochem. Biophys. Res. Commun. 195,179-185.
13. O'Dowd, B. F., Lee, D. K., Huang, W., Nguyen, T., Cheng, R., Liu, Y., et al. (2000). TRH-R2 exhibits similar binding but distinct regulation and anatomic distribution compared to TRH-R1. Mol. Endocrinol. 14, 183-193.
14. Sun, Y., Lu, X., and Gershengorn, M. C. (2003). Thyrotropin-releasing hormone receptors - similarities and differences. J. Mol. Endocrinol. 30, 87-97.
15. Suzuki, M., Sugano, H., Matsumoto, K., Yamamura, M., and Ishida,R. (1990). Synthesis and central nervous system actions of thyrotropin-releasing hormone analogues containing a dihy-droorotic acid moiety. J. Med. Chem. 33,2130-2137.
16. Yamamura, M., Kinoshita, K., Nak-agawa, H., and Ishida, R. (1991). Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (III): inhibition of pentobarbital anesthesia. Jpn. J. Pharmacol. 55, 69-80.
17. Yamamura, M., Suzuki, M., and Matsumoto, K. (1997). Synthesis and pharmacological action of TRH analog pep tide (taltirelin). Nihon Yakurigaku Zasshi 110(Suppl. 1), P33-P38.